NTUS

NASDAQ:NTUS

Natus Medical Incorporated

  • Stock

USD

Last Close

32.96

24/04 19:47

Volume Today

132.70K

Avg: 339.69K

PE Ratio

84.22

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
net income
32.48M
-
37.92M
16.77%
42.59M
12.31%
-20.29M
147.64%
-22.93M
13.02%
-15.67M
31.67%
-16.61M
6.01%
13.18M
179.32%
depreciation and amortization
11.76M
-
15.99M
35.96%
16.88M
5.58%
30.10M
78.32%
33.86M
12.51%
30.72M
9.28%
28.11M
8.49%
28.09M
0.09%
deferred income tax
stock based compensation
6.06M
-
6.95M
14.70%
9.01M
29.56%
9.45M
4.85%
17.05M
80.53%
8.35M
51.02%
9.57M
14.54%
14.16M
48.03%
change in working capital
-6.70M
-
-29.13M
334.55%
178K
100.61%
-16.56M
9,405.62%
-27.82M
67.95%
7.17M
125.76%
-154K
102.15%
2.93M
2,005.19%
accounts receivables
-2.43M
-
-15.27M
528.22%
19.72M
229.14%
-30.47M
254.50%
-5.20M
82.94%
9.82M
288.82%
17.65M
79.80%
-13.11M
174.28%
inventory
-2.02M
-
-12.23M
506.45%
-7.67M
37.31%
7.58M
198.87%
-7.44M
198.18%
7.18M
196.53%
1.94M
73.01%
4.83M
149.10%
accounts payables
-7.65M
-
3.27M
142.76%
-4.96M
251.83%
-1.39M
72.10%
4.11M
396.39%
-1.37M
133.30%
-4.52M
230.87%
13.53M
399.14%
other working capital
5.39M
-
-4.89M
190.75%
-6.91M
41.23%
7.71M
211.59%
-19.28M
350.01%
-8.47M
56.09%
-15.22M
79.75%
-2.31M
84.79%
other non cash items
-1.45M
-
5.12M
452.10%
4.03M
21.27%
17.04M
323.04%
32.86M
92.85%
29.49M
10.26%
13.51M
54.18%
5.63M
58.32%
net cash provided by operating activities
42.14M
-
36.85M
12.55%
72.69M
97.24%
19.73M
72.86%
33.02M
67.39%
60.06M
81.89%
34.43M
42.68%
63.99M
85.89%
investments in property plant and equipment
-5.72M
-
-5.19M
9.20%
-3.40M
34.62%
-4.07M
19.73%
-8.54M
110.03%
-5.34M
37.48%
-8.61M
61.25%
-3.62M
57.95%
acquisitions net
-4.92M
-
-14.28M
190.03%
-15.85M
10.96%
-190.89M
1,104.42%
151K
100.08%
-4.00M
-
-1M
74.98%
purchases of investments
-34.02M
-
sales maturities of investments
210K
-
34.02M
16,099.52%
other investing activites
-210K
-
2.67M
-
net cash used for investing activites
-10.64M
-
-19.48M
82.98%
-53.26M
173.46%
-160.94M
202.15%
-8.39M
94.79%
-5.34M
36.36%
-12.61M
136.11%
-1.95M
84.56%
debt repayment
-38.02M
-
-16M
-
-45M
181.25%
-50M
11.11%
-50.48M
0.96%
-58.53M
15.95%
-57.41M
1.91%
common stock issued
common stock repurchased
-4.63M
-
-11.53M
148.76%
-19.29M
67.37%
-2.27M
88.24%
-5.63M
148.24%
-10.49M
-
dividends paid
other financing activites
21.74M
-
12.36M
43.15%
153.71M
1,143.88%
53.09M
65.46%
6.12M
88.48%
1.95M
68.19%
58.15M
2,887.92%
-3.25M
105.59%
net cash used provided by financing activities
-20.91M
-
832K
103.98%
118.42M
14,132.81%
5.83M
95.08%
-49.51M
949.85%
-48.53M
1.98%
-10.88M
77.59%
-60.66M
457.71%
effect of forex changes on cash
-132K
-
-2.29M
1,638.64%
-6.76M
194.47%
10.78M
259.54%
-7.70M
171.38%
735K
109.55%
7.84M
966.94%
-7.87M
200.41%
net change in cash
10.45M
-
15.91M
52.23%
131.08M
723.85%
-124.60M
195.06%
-32.58M
73.85%
6.92M
121.25%
18.79M
171.30%
-6.49M
134.53%
cash at beginning of period
56.11M
-
66.56M
18.63%
82.47M
23.91%
213.55M
158.95%
88.95M
58.35%
56.37M
36.62%
63.30M
12.28%
82.08M
29.68%
cash at end of period
66.56M
-
82.47M
23.91%
213.55M
158.95%
88.95M
58.35%
56.37M
36.62%
63.30M
12.28%
82.08M
29.68%
75.59M
7.90%
operating cash flow
42.14M
-
36.85M
12.55%
72.69M
97.24%
19.73M
72.86%
33.02M
67.39%
60.06M
81.89%
34.43M
42.68%
63.99M
85.89%
capital expenditure
-5.72M
-
-5.19M
9.20%
-3.40M
34.62%
-4.07M
19.73%
-8.54M
110.03%
-5.34M
37.48%
-8.61M
61.25%
-3.62M
57.95%
free cash flow
36.42M
-
31.66M
13.08%
69.29M
118.87%
15.66M
77.40%
24.48M
56.32%
54.72M
123.53%
25.82M
52.82%
60.38M
133.86%

All numbers in USD (except ratios and percentages)